User profiles for Aiysha Chaudhry
 | Aiysha ChaudhryUCL Institute of Neurology Verified email at ucl.ac.uk Cited by 60 |
Activity of ceftolozane/tazobactam against surveillance and 'problem' Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles
…, R Hill, R Adkin, A Chaudhry… - Journal of …, 2017 - academic.oup.com
Background: We assessed the activity of ceftolozane/tazobactam against consecutive
isolates collected in the BSAC Bacteraemia Surveillance from 2011 to 2015 and against ‘problem’ …
isolates collected in the BSAC Bacteraemia Surveillance from 2011 to 2015 and against ‘problem’ …
Comparing fluid biomarkers of Alzheimer's disease between African American or Black African and white groups: A systematic review and meta-analysis
A Chaudhry, M Rizig - Journal of the Neurological Sciences, 2021 - Elsevier
Rationale Biomarker research for Alzheimer's disease (AD) has grown rapidly in recent years,
ensuing the integration of the AD fluid biomarker profile: Aβ1-42, t-tau, and p-tau 181 , into …
ensuing the integration of the AD fluid biomarker profile: Aβ1-42, t-tau, and p-tau 181 , into …
Inherent colistin resistance in genogroups of the Enterobacter cloacae complex: epidemiological, genetic and biochemical analysis from the BSAC Resistance …
…, R Adkin, I García-Romero, A Chaudhry… - Journal of …, 2020 - academic.oup.com
Background Polymyxins have re-entered use against problem Gram-negative bacteria.
Resistance rates are uncertain, with estimates confounded by selective testing. Methods The …
Resistance rates are uncertain, with estimates confounded by selective testing. Methods The …
Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review
Rationale Frontotemporal dementia (FTD) and dementia with Lewy bodies (DLB) are two
common forms of neurodegenerative dementia, subsequent to Alzheimer's disease (AD). AD is …
common forms of neurodegenerative dementia, subsequent to Alzheimer's disease (AD). AD is …
[HTML][HTML] DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder
Dentatorubral–pallidoluysian atrophy (DRPLA) is a rare neurodegenerative disorder
caused by CAG repeat expansions in the atrophin-1 gene and is inherited in an autosomal …
caused by CAG repeat expansions in the atrophin-1 gene and is inherited in an autosomal …
Genomic sequences of Streptococcus agalactiae with high-level gentamicin resistance, collected in the BSAC bacteraemia surveillance
…, S Mushtaq, V Martin, A Chaudhry… - Journal of …, 2017 - academic.oup.com
Background Like other streptococci, Streptococcus agalactiae typically has intrinsic low-level
aminoglycoside resistance. High-level gentamicin resistance was seen in 2 of 1125 …
aminoglycoside resistance. High-level gentamicin resistance was seen in 2 of 1125 …
Inoculum effects of cefepime/zidebactam (WCK 5222) and ertapenem/zidebactam (WCK 6777) for Enterobacterales in relation to β-lactamase type and enhancer …
S Mushtaq, A Vickers, A Chaudhry… - Journal of …, 2022 - academic.oup.com
Objectives Combinations of PBP3-active β-lactams with developmental diazabicyclooctanes
(DBOs), eg zidebactam, remain active against many MBL producers via an enhancer effect. …
(DBOs), eg zidebactam, remain active against many MBL producers via an enhancer effect. …
In vitro activity of telavancin and comparators against selected groups of Gram-positive cocci
R Hope, A Chaudhry, R Adkin, DM Livermore - International journal of …, 2013 - Elsevier
Telavancin is a novel, rapidly cidal, dual-action glycopeptide. This study examined its in
vitro activity against relevant Gram-positive pathogens, comprising 99 meticillin-resistant …
vitro activity against relevant Gram-positive pathogens, comprising 99 meticillin-resistant …
The State of Play of Parkinson's Disease in Africa: A Systematic Review and Point of View.
…, P Adebayo, EGB Lamou, L Chishimba, A Chaudhry… - medRxiv, 2023 - medrxiv.org
Background: Parkinson's disease (PD) has become a global public health challenge as
disability and death due to the disease are growing rapidly in comparison to other neurological …
disability and death due to the disease are growing rapidly in comparison to other neurological …
Correction to: DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder
A Chaudhry, A Athanasiou-Fragkouli… - Journal of …, 2021 - ncbi.nlm.nih.gov
… Aiysha Chaudhry, Alkyoni Athanasiou-Fragkouli, Hector Garcia-Moreno, Silvia Prades
Abadias, corresponding author Julie Greenfield, Yael Shiloh-Malawsky, Paola Giunti, and …
Abadias, corresponding author Julie Greenfield, Yael Shiloh-Malawsky, Paola Giunti, and …
